[ Price : $8.95]
Federal Register notice: FDA determines the regulatory review period for La Jolla Pharmaceuticals Giapreza (angiotensin II).[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Drugs for Treatment of Partial Onset Seizures: Full Extrapo...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension for Guidance for Industry on E6 (R2) Good Clini...[ Price : $8.95]
FDA clears a Bardy Diagnostics 510(k) for its 14-Day version of the Carnation Ambulatory Monitor, a P-wave heart monitor.[ Price : $8.95]
Endo International files a BLA for collagenase clostridium histolyticum for treating cellulite in the buttocks.[ Price : $8.95]
CDER director Janet Woodcock says addiction currently is the most serious threat to public health.[ Price : $8.95]
FDA approves Boehringer Ingelheim Pharmaceuticals Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in ...[ Price : $8.95]
FDA seeks comment on a discussion paper on how to determine and consider benefit and risk in weight-loss medical devices.